New Baveno VII Guidelines Further Validate FibroScan by Echosens for Management of Patients with Advanced Chronic Liver Disease

Echosens, a high-technology company offering the FibroScan portfolio of solutions, is pleased to announce that the latest Baveno VII guidelines fully support the effectiveness of FibroScan technologies

Related Keywords

Kostenloser Wertpapierhandel ,Lsmabout Echosens ,Dominique Legros ,Brittany Tedesco , ,Baveno ,Guidelines ,Urther ,Validate ,Fibroscan ,Echosens ,Management ,Patients ,Dvanced ,Hronic ,Liver ,Disease ,